Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta‐analysis
Authors:
- Kendal YalçιnKYKendal Yalçιn
- Mustafa YakutMYMustafa Yakut
- Cihan YurdaydinCYCihan Yurdaydin
- 12 March 2008
- journal article
- Published by Wiley in Liver International
- Vol. 28 (4) , 494-498
Abstract
Background: Recent reports suggest a decline of delta hepatitis (DH) in the West as well as in the Far East.Aim: To study the DH seroepidemiology in Turkey.Methods: Statistical power analysis was utilized based on data available in a recent article using prevalence figure estimates. Binominal distribution was applied in order to assess the number of samples required to estimate the prevalence with a given precision.Results: Out of 62 studies in the original study, 32 were eliminated because of insufficient power. A total of 6734 patients (5231 with chronic hepatitis and 1503 with cirrhosis) were analysed. Anti‐HDV seropositivity among patients with chronic hepatitis B (CHB) and hepatitis B‐induced cirrhosis was lowest in the west of the country and highest in the southeast (5 vs. 27%, PPPP=0.03) in central and southeast Turkey and from 38 to 20% (PPConclusion: Despite the decrease of its prevalence in Turkey, DH remains a significant health problem in parts of the country with low socio‐economic level.Keywords
This publication has 7 references indexed in Scilit:
- Hepatitis D virus infection—Not a vanishing disease in Europe!†Hepatology, 2007
- Liver transplantation plenaryHepatology, 2003
- In MemoriamPsychiatric News, 2001
- Risk Factors for Hepatocellular Carcinoma in TurkeyDigestive Diseases and Sciences, 2001
- Decreasing hepatitis D virus infection in Taiwan: An analysis of contributory factorsJournal of Gastroenterology and Hepatology, 1997
- Decrease in HDV endemicity in ItalyJournal of Hepatology, 1997
- A study on delta virus infection and its clinical impact in IranInfection, 1990